English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Hypothesis / aims of study The patients with irrevisible contracted bladder or lower compliance due to different disease might be clinically categorized to end stage bladder diseases (ESBD). Conventionally, augmentation enterocystoplasty (AE) is indicated in ESBD patients and could effectively imporve clinical symptoms. However, the outcome and complication between different etiologies had not been reported and compared. We reported the long-term results of currently largest series of patients with ESBD and recived AE.

Single institution experience of over 100 cases of augmentation enterocystoplasty in the patients with end-stage bladder diseases